Steris Corp Third Quarter Earnings Sneak Peek

Steris Corp (NYSE:STE) will unveil its latest earnings on Tuesday, February 7, 2012. STERIS is a provider of infection prevention and surgical products and services, focused mainly on the critical markets of healthcare, pharmaceutical and research.

Steris Corp Earnings Preview Cheat Sheet

Wall St. Earnings Expectations: The average estimate of analysts is for net income of 61 cents per share, a rise of 7% from the company’s actual earnings for the same quarter a year ago. During the past three months, the average estimate has moved down from 63 cents. Between one and three months ago, the average estimate moved down. It has been unchanged at 61 cents during the last month. Analysts are projecting profit to rise by 1.4% versus last year to $2.22.

Past Earnings Performance: The company showed profit of 46 cents per share versus a mean estimate of net income of last quarter. This marks the fourth month of falling short of estimates.

Investing Insights: Will the iPad 3 Be the Next Catalyst for Apple’s Stock?

Wall St. Revenue Expectations: On average, analysts predict $363.4 million in revenue this quarter, a rise of 10.7% from the year ago quarter. Analysts are forecasting total revenue of $1.41 billion for the year, a rise of 16.5% from last year’s revenue of $1.21 billion.

Analyst Ratings: three out of five analysts surveyed (60%) have a buy rating on Steris.. This is below the mean analyst rating of 10 competitors, which average 67.5% buy ratings.

A Look Back: In the second quarter, profit fell 17.2% to $29.6 million (50 cents a share) from $35.7 million (59 cents a share) the year earlier, missing analyst expectations. Revenue rose 9.7% to $342.7 million from $312.4 million.

Key Stats:

Revenue has risen the past four quarters. Revenue rose 68.6% in the first quarter from the year earlier, climbed 13.7% in the fourth quarter of the last fiscal year from the year-ago quarter and 0.1% in the third quarter of the last fiscal year.

Stock Price Performance: During November 3, 2011 to February 1, 2012, the stock price had risen $1.41 (4.9%) from $28.71 to $30.12. The stock price saw one of its best stretches over the last year between April 18, 2011 and April 29, 2011 when shares rose for nine-straight days, rising 7.1% (+$2.35) over that span. It saw one of its worst periods between November 15, 2011 and November 23, 2011 when shares fell for seven-straight days, falling 7.2% (-$2.12) over that span.

(Company fundamentals by Xignite Financials. Earnings estimates provided by Zacks)

Don’t Miss These Additional Hot Earnings Preview Stories: Inc. Fourth Quarter Earnings Sneak Peek

Humana Inc. Fourth Quarter Earnings Sneak Peek

Yum! Brands Inc. Fourth Quarter Earnings Sneak Peek

To contact the reporter on this story: Derek Hoffman at

To contact the editor responsible for this story: Damien Hoffman at